“The existing problem has uncovered some structural weaknesses inside the EU’s medicines source chain plus a significant dependence on non-EU nations for active pharmaceutical ingredients,” Kyriakides explained. She advised that offer chain troubles be addressed in an EU pharmaceutical tactic predic… Read More